Lanjuan Li

State Key Laboratory of Diagnosis and Treatment of Infectious Diseases

Research Areas

• Gut microbiota and health
• Diet and metabolism studies
• Probiotics and Fermented Foods
• Advanced biosensing and bioanalysis techniques
• Wastewater Treatment and Nitrogen Removal

Health Outcomes Studied

• Improved Gut Microbiome
• Improved Gut Microbiota
• Improved Gut Microbiota Composition
• Improved Gut Microbiota Diversity
• Increased Energy Levels
• Increased Interleukin-10 Levels
• Increased SCFA Levels
• Reduced Body Weight

Papers (18)

• 2025
  Bioartificial liver: Where lies the path ahead-A review.10.1097/hc9.0000000000000788
• 2025
  Lactobacillus helveticus R0052 attenuates DSS-induced colitis via modulation of gut microbiota, intestinal metabolites and immunological profiles in a mouse model.10.1016/j.micpath.2025.108002
• 2024
  The Efficacy of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.10.3390/nu16132114
• 2022
  The synergy of dietary supplements Lactobacillus salivarius LI01 and Bifidobacterium longum TC01 in alleviating liver failure in rats treated with D-galactosamine.10.1039/d1fo01807h
• 2021
  Lactobacillus reuteri DSM 17938 alleviates d-galactosamine-induced liver failure in rats.10.1016/j.biopha.2020.111000
• 2021
  Probiotic Lactobacillus casei Shirota prevents acute liver injury by reshaping the gut microbiota to alleviate excessive inflammation and metabolic disorders10.1111/1751-7915.13750
• 2021
  Impact of encapsulating a probiotic (Pediococcus pentosaceus Li05) within gastro-responsive microgels on Clostridium difficile infections.10.1039/d0fo03235b
• 2021
  Effects of Pediococcus pentosaceus LI05 on immunity and metabolism in germ-free rats.10.1039/d0fo02530e
• 2021
  Pediococcus pentosaceus, a future additive or probiotic candidate10.1186/s12934-021-01537-y
• 2021
  Modulation of the immune response and metabolism in germ-free rats colonized by the probiotic Lactobacillus salivarius LI0110.1007/s00253-021-11099-z
• 2020
  Pediococcus pentosaceus LI05 alleviates DSS‐induced colitis by modulating immunological profiles, the gut microbiota and short‐chain fatty acid levels in a mouse model10.1111/1751-7915.13583
• 2020
  New strain of Pediococcus pentosaceus alleviates ethanol-induced liver injury by modulating the gut microbiota and short-chain fatty acid metabolism10.3748/wjg.v26.i40.6224
• 2020
  Administration of Bifidobacterium bifidum CGMCC 15068 modulates gut microbiota and metabolome in azoxymethane (AOM)/dextran sulphate sodium (DSS)-induced colitis-associated colon cancer (CAC) in mice10.1007/s00253-020-10621-z
• 2019
  Lactobacillus helveticus R0052 alleviates liver injury by modulating gut microbiome and metabolome in d-galactosamine-treated rats10.1007/s00253-019-10211-8
• 2018
  Bifidobacterium adolescentis CGMCC 15058 alleviates liver injury, enhances the intestinal barrier and modifies the gut microbiota in d-galactosamine-treated rats10.1007/s00253-018-9454-y
• 2018
  Protective Effect of Pediococcus pentosaceus LI05 Against Clostridium difficile Infection in a Mouse Model10.3389/fmicb.2018.02396
• 2017
  Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl4-induced liver cirrhosis by protecting the intestinal barrier in rats10.1038/s41598-017-07091-1
• 2017
  Integrated transcriptomic and proteomic analysis of the bile stress response in probiotic Lactobacillus salivarius LI01.10.1016/j.jprot.2016.08.021